A patient with low Mg (1.2 mg/dL) is at risk for refractory hypokalemia. What is the management?

Prepare for the Mark Klimek Electrolytes and Endocrine Test. Utilize flashcards, multiple choice questions, and detailed explanations for each query to enhance your understanding. Ace your exam!

Multiple Choice

A patient with low Mg (1.2 mg/dL) is at risk for refractory hypokalemia. What is the management?

Explanation:
Magnesium status dictates potassium handling. When magnesium is low, the kidneys waste potassium and make it hard to raise the potassium level with potassium alone. The low Mg impairs the mechanisms that normally retain potassium (including the Na+/K+-ATPase function and renal potassium transport), so potassium replacement often remains ineffective until Mg is corrected. By administering magnesium sulfate to fix the deficiency, renal potassium loss decreases and potassium repletion becomes effective, reducing the chance of recurrent hypokalemia. After Mg is corrected, continue with potassium replacement and monitor both Mg and K+ levels to ensure sustained correction.

Magnesium status dictates potassium handling. When magnesium is low, the kidneys waste potassium and make it hard to raise the potassium level with potassium alone. The low Mg impairs the mechanisms that normally retain potassium (including the Na+/K+-ATPase function and renal potassium transport), so potassium replacement often remains ineffective until Mg is corrected. By administering magnesium sulfate to fix the deficiency, renal potassium loss decreases and potassium repletion becomes effective, reducing the chance of recurrent hypokalemia. After Mg is corrected, continue with potassium replacement and monitor both Mg and K+ levels to ensure sustained correction.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy